慢性病流行病学(肿瘤为主),数智化驱动的药物/罕见病流行病学,数智化技术的开发及应用
1. 国家重点研发计划,肺血栓栓塞症综合防治体系卫生经济学评价及政策转化研究,课题负责人
2. 国家自然科学基金专项,数智化驱动的罕见病多重保障机制设计与实证研究,课题负责人
3. 首都卫生发展科研专项重点攻关项目,大数据驱动的北京市疫苗安全性主动监测策略和技术研究,课题负责人
4. 国家重点研发计划,老年泌尿功能人群队列及数据平台建设,分任务单元负责人
5. 首都卫生发展科研专项重点攻关项目,北京市前列腺癌精准筛查及卫生经济学评估研究,联合负责人
6. 国家自然科学基金面上项目,基于动态贝叶斯网络和迁移学习处理药品不良反应预测中时依性变量的策略与实证研究,负责人
7. 国家电网公司科学技术项目,电网企业职业危害突发事件风险评估技术及防控策略研究,子课题负责人
8. 国家重点研发计划,基于人群肿瘤登记数据和医院诊疗数据的采集标准和共享机制研究,分任务单元负责人
9. 总理基金项目分课题,大气污染导致肺癌等主要症的归因风险与疾病负担研究,分任务单元负责人
10. 国家自然科学基金青年项目,利用电子病历开展药品不良反应主动监测如何选择对照的方法学研究,负责人
1. Ding Ranyi#, Wang Yutong#, Yu Yuelin#, Meng Xianglong, Gong Quanquan, Tang Yuchuan, Wang Jinhao, Mu Xianlin, Li Huiping, Zhou Huziwei, Wang Shengfeng*, Liu Ping*. Effectiveness of a Multifaceted Intervention (TEMP) for Prevention of Occupational Heat-Related Illness among Outdoor Workers in the Power Grid Industry: A Cluster Randomized Controlled Trial. Environ Health Perspect, 2025,133(1):17001. (数智化干预的整群随机对照试验,IF = 10.100)
2. Dong Xiaowu, Zhu Qingtian, Yuan Chenchen, Wang Yaodong, Ma Xiaojie, Shi Xiaolei, Chen Weiwei, Dong Zhao, Chen Lin, Shen Qinhao, Xu Hongwei, Ding Yanbing, Gong Weijuan, Xiao Weiming, Wang Shengfeng*, Li Weiqin*, Lu Guotao*. Associations of intra-pancreatic fat deposition with incident diseases of the exocrine and endocrine pancreas: A UK Biobank prospective cohort study. Am J Gastroenterol. 2024,119(6):1158-1166. (IF = 12.600)
3. Xu lu, He Bingjie, Sun Yexiang, Li Jun, Shen Peng, Hu Liming, Liu Guozhen, Wang Jinxi, Duan Liping*, Zhan Siyan*, Wang Shengfeng*. Incidence of Inflammatory Bowel Disease in Urban China: A Nationwide Population-based Study. Clin Gastroenterol Hepatol, 2023, 21(13):3379-3386. (IF = 12.600)
4. Zheng Xuanqi#, Xu Lu#, Huang Jie, Zhang Chenggui, Yuan Wanqiong, Sun Chuiguo, Zhang Zhishan, Wei Chen, Wang Jinxi, Cummings Steven R, Xia Weibo, Wang Shengfeng*, Zhan Siyan*, Song Chunli*. Incidence and cost of vertebral fracture in urban China: A five-year population-based cohort study. Int J Surg. 2023, 109(7):1910-1918. (IF = 15.300)
5. Wen Qiaorui#, Liu Tanxin#, Yu Yuelin#, Zhang Yunjing, Yang Yingzi, Zheng Rongshou, Li Liming, Chen Ru*, Wang Shengfeng*. Self-Reported Primary Cooking Fuels Use and Risk of Chronic Digestive Diseases: A Prospective Cohort Study of 0.5 Million Chinese Adults. Environ Health Perspect. 2023, 131(4):47002. (IF = 11.305)
6. Zhou Huziwei#, Qiao Liying#, Zhang Yunjing, Kang Weiwei, Yan xue, Jiang Yuling, Ke Yalei, Rao Yingting, Liu Guozhen, Wang Mingyuan, Wang Hui, Xi Yunfeng*, Wang Shengfeng*. Association of Ethnicity, Sex, and Age With Cancer Diagnoses and Health Care Utilization Among Children in Inner Mongolia, China. JAMA Network Open. 2022, 5(9):e2231182. (IF = 13.360)
7. Chen Fangfang#, Cai Chang#, Wang Shengfeng#, Qin Qianqian, Jin Yichen , Li Dongmin, Ge Lin, Li Peilong, Cui Yan, Tang Houlin*, Lv Fan*.Trends in suicide mortality among people with HIV after diagnosis during 2012-18: a retrospective, national cohort study in China. Lancet HIV. 2022, 9(2):e102-e111. (IF = 16.070)
8. Sun Yixin#, Zhou Guoyu#, Feng Jingnan, Chen Lu, Liu Gguozhen, Wang Jinxin, Wang Qingliang, Yu Junyou, Yang Xiwang, Yang Zheng, Gao Pei*, Wang Shengfeng*, Zhan Siyan*. Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study. Stroke and vascular neurology,2021, 6(4), 615–623. (IF = 9.893,入选北京市科协2023年首都前沿学术成果[脑科学领域])
9. Zhang Chenggui#, Feng Jingnan#, Wang Shengfeng#, Gao Pei#, Xu Lu, Zhu Junxiong, Jia Jialin, Liu Lili, Liu Guozhen, Wang Jinxi, Zhan Siyan*, Song Chunli*; Incidence of and trends in hip fracture among adults in urban China: a nationwide retrospective cohort study. PLOS Medicine, 2020, 17(8):e1003180. (IF = 11.069)
10. Xu Lu#; Chen Lu#; Wang Shengfeng#; Feng Jingnan; Liu Lili; Liu Guozhen; Wang Jinxi; Zhan Siyan*; Gao Pei; Fan Dongsheng; Incidence and prevalence of amyotrophic lateral sclerosis in urban China: a national population-based study, Journal of Neurology, Neurosurgery, and Psychiatry, 2020, 91:520-525. (IF =10.283,入选中国2020年度重要医学进展)